OMC

OUP Management Company Portfolio holdings

AUM $44.5M
This Quarter Return
-5.59%
1 Year Return
+54.04%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$50.1M
AUM Growth
+$50.1M
Cap. Flow
-$4.85M
Cap. Flow %
-9.67%
Top 10 Hldgs %
96.74%
Holding
14
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

1
IONQ icon
IonQ
IONQ
$4.85M

Sector Composition

1 Healthcare 95.22%
2 Technology 4.78%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
JBIO
1
Jade Biosciences, Inc. Common Stock
JBIO
$258M
$12.2M 24.3% 603,762 – –
CNTA
2
Centessa Pharmaceuticals
CNTA
$2.25B
$11.3M 22.57% 2,937,615 – –
DICE
3
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$7.69M 15.34% 268,346 – –
PMVP icon
4
PMV Pharmaceuticals
PMVP
$74.2M
$4.72M 9.42% 989,232 – –
CYT
5
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$4.48M 8.93% 2,459,572 – –
IONQ icon
6
IonQ
IONQ
$12.7B
$2.4M 4.78% 389,668 -787,929 -67% -$4.85M
VOR icon
7
Vor Biopharma
VOR
$250M
$2.02M 4.02% 374,714 – –
PRME icon
8
Prime Medicine
PRME
$578M
$1.49M 2.98% 121,255 – –
RNAC icon
9
Cartesian Therapeutics
RNAC
$261M
$1.2M 2.39% 862,543 – –
LENZ
10
LENZ Therapeutics
LENZ
$1.1B
$995K 1.99% 406,308 – –
DTIL icon
11
Precision BioSciences
DTIL
$57.8M
$847K 1.69% 1,123,913 – –
EFTR
12
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$362K 0.72% 1,025,697 – –
SPRO icon
13
Spero Therapeutics
SPRO
$116M
$361K 0.72% 249,070 – –
QTTB icon
14
Q32 Bio
QTTB
$20.9M
$65.9K 0.13% 64,000 – –